Daniel N. Swisher, Jr
2010 - Sunesis Pharmaceuticals
In 2010, Daniel N. Swisher, Jr earned a total compensation of $641.3K as CEO and President at Sunesis Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $232,875 |
|---|---|
| Salary | $405,000 |
| Other | $3,455 |
| Total | $641,330 |
Swisher received $405K in salary, accounting for 63% of the total pay in 2010.
Swisher also received $232.9K in non-equity incentive plan and $3.5K in other compensation.
Rankings
In 2010, Daniel N. Swisher, Jr's compensation ranked 6,857th out of 10,439 executives tracked by ExecPay. In other words, Swisher earned more than 34.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,857 out of 10,439 | 34th |
Division Manufacturing | 2,493 out of 3,838 | 35th |
Major group Chemicals And Allied Products | 582 out of 921 | 37th |
Industry group Drugs | 384 out of 680 | 44th |
Industry Pharmaceutical Preparations | 292 out of 481 | 39th |
Source: SEC filing on April 25, 2013.
Swisher's colleagues
We found two more compensation records of executives who worked with Daniel N. Swisher, Jr at Sunesis Pharmaceuticals in 2010.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019